Related Experiment Video
Updated: Nov 1, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Assessment of Kidney Function After Transcatheter Aortic Valve Replacement
Orit Kliuk-Ben Bassat1, Sapir Sadon2, Svetlana Sirota2
1Department of Nephrology, Tel Aviv Medical Center, Sackler School of Medicine, Tel Aviv University, Israel.
Kidney function improvement after transcatheter aortic valve replacement (TAVR) is uncommon and does not impact long-term mortality. Acute kidney injury following TAVR, however, is associated with increased mortality.
Area of Science:
- Cardiology
- Nephrology
- Interventional Cardiology
Background:
- Transcatheter aortic valve replacement (TAVR) carries a risk of acute kidney injury (AKI), but may also improve renal function.
- Understanding kidney function changes post-TAVR is crucial for patient outcomes.
Purpose of the Study:
- To quantify kidney function improvement (KFI) after TAVR.
- To assess the impact of KFI on long-term mortality.
Main Methods:
- Prospective, single-center study of 1321 patients undergoing TAVR.
- Serum creatinine measured pre- and post-procedure (up to 7 days).
- KFI defined by specific creatinine reduction criteria; patients grouped into KFI, AKI, or preserved kidney function (PKF).
Main Results:
- KFI occurred in 5% of patients, often minor.
- AKI incidence was 19.1%.
- Lower eGFR predicted KFI; KFI group had higher STS scores. Mortality was similar between KFI and PKF groups but significantly higher in the AKI group.
Conclusions:
- Kidney function improvement post-TAVR is infrequent and did not reduce mortality in this cohort.
- Limitations include single-center design and varied KFI definitions.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Kidney Transplant III: Nursing Management
Kidney Transplant I: Introduction
Cardiac Catheterization I: Pre-Procedure Overview
Acute Kidney Injury III: Clinical Manifestations
Imaging Studies VII: Vascular Imaging

